Question to the Department of Health and Social Care:

To ask Her Majesty's Government what processes they will adopt to ensure that eligible repurposed medicines are included in horizon scanning to identify products for the Accelerated Access Pathway, as highlighted in their response to the Accelerated Access Review.

The Accelerated Access Collaborative (AAC) will begin product selection from April onwards. We were explicit in the response that repurposed medicines would be eligible for consideration of their suitability for the pathway. We anticipate that the AAC will publish further details on the process and criteria for the pathway ahead of the pathway opening in April 2018.